Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant changes to core content or time-sensitive information detected; updates appear to be only date-related entries and deletions of some earlier dates.
    Difference
    0.2%
    Check dated 2025-10-22T06:30:21.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - Location designation updated from Rhône-Alpes to Auvergne-Rhône-Alpes for Lyon with postal code unchanged. - Revision bumped from v3.1.0 to v3.2.0. - Added general government-operating-status notice (lower impact).
    Difference
    4%
    Check dated 2025-10-07T23:10:53.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0, updating the page revision/version metadata.
    Difference
    0.0%
    Check dated 2025-09-30T02:16:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page is updated to v3.0.2 from v3.0.1, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-15T19:23:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-08T15:01:46.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous locations across various countries and the inclusion of detailed drug information for specific medications. Notably, the facility name and location have been added, enhancing the core content of the page.
    Difference
    24%
    Check dated 2025-09-01T09:33:40.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.